UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Planning an Academic Clinical Trial

Methods in molecular biology (Clifton, N.J.), 2015, Vol.1317, p.287

2015

Volltextzugriff (PDF)

Phase III Trial of High-Dose Sequential Chemotherapy With Peripheral Blood Stem Cell Support Compared With Standard Dose Chemotherapy for First-Line Treatment of Advanced Ovarian Cancer: Intergroup Trial of the AGO-Ovar/AIO and EBMT

Journal of clinical oncology, 2007-09, Vol.25 (27), p.4187-4193

2007

Volltextzugriff (PDF)

Expert Commentary on Anal Fissure

Diseases of the colon & rectum, 2018-03, Vol.61 (3), p.296-297

Lu, Kim Champion

2018

Volltextzugriff (PDF)

Chromosome 20 deletions in myeloid malignancies : reduction of the common deleted region, generation of a PAC/BAC contig and identification of candidate genes

Oncogene, 2000-08, Vol.19 (34), p.3902-3913

2000

Volltextzugriff (PDF)

Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR

Nature medicine, 2019-09, Vol.25 (9), p.1408-1414

2019

Volltextzugriff (PDF)

A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA Working Party of the European Group for Blood and Marrow Transplantation

Blood, 2011-04, Vol.117 (17), p.4434-4441

2011

Volltextzugriff (PDF)

Clonal Dynamics of Early Responder and Long-Term Surviving CAR-T Cells in Humans

Blood, 2019-11, Vol.134 (Supplement_1), p.52-52

2019

Volltextzugriff (PDF)

Clonal haemopoiesis in normal elderly women: implications for the myeloproliferative disorders and myelodysplastic syndromes

British journal of haematology, 1997-06, Vol.97 (4), p.920-926

1997

Volltextzugriff (PDF)

Abstract CT105: AUTO1, a novel fast off CD19CAR delivers durable remissions and prolonged CAR T cell persistence with low CRS or neurotoxicity in adult ALL

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.CT105-CT105

2019

Volltextzugriff (PDF)

TACTICAL: A phase I/II trial to assess the safety and efficacy of MSCTRAIL in the treatment of metastatic lung adenocarcinoma

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.TPS9116-TPS9116

2019

Volltextzugriff (PDF)

AUTO1, a Novel Fast Off CD19CAR Delivers Durable Remissions and Prolonged CAR T Cell Persistence with Low CRS or Neurotoxicity in Adult ALL

Blood, 2019-11, Vol.134 (Supplement_1), p.226-226

2019

Volltextzugriff (PDF)

Therapy of Paediatric B-ALL with a Fast Off Rate CD19 CAR Leads to Enhanced Expansion and Prolonged CAR T Cell Persistence in Patients with Low Bone Marrow Tumour Burden, and Is Associated with a Favourable Toxicity Profile

Blood, 2019-11, Vol.134 (Supplement_1), p.225-225

2019

Volltextzugriff (PDF)

A Novel Second Generation CD19 CAR for Therapy of High Risk/Relapsed Paediatric CD19+ Acute Lymphoblastic Leukaemia and Other Haematological Malignancies: Preliminary Results from the Carpall Study

Blood, 2016-12, Vol.128 (22), p.4026-4026

2016

Volltextzugriff (PDF)

Automated Manufacture of CAR19 Donor Lymphocytes Incorporated into an Escalated Dose DLI Protocol: Preliminary Results from the CARD Study

Blood, 2017-12, Vol.130, p.1993-1993

2017

Volltextzugriff (PDF)

452. RegenVOX - Translational Exploitation Strategy for Stem Cell-Based Tissue-Engineered Laryngeal Implants Undergoing Phase I/II Clinical Trial

Molecular therapy, 2016-05, Vol.24, p.S179-S180

2016

Volltextzugriff (PDF)

Vaccination - a Novel Strategy to Improve the Persistence of CD19CAR Transduced T-Cells in Relapsed Paediatric ALL: Preliminary Results from the CD19TPALL Study

Blood, 2014-12, Vol.124 (21), p.383-383

2014

Volltextzugriff (PDF)

Use of G-CSF in Patients with Severe Aplastic Anemia Treated with ATG and Cyclosporine Increases Neutrophils and Decreases Infection Rates and Hospitalization Days but Does Not Improve Long-Term Outcome: Results of a Prospective, Randomized Clinical Trial of the EBMT

Blood, 2009-11, Vol.114 (22), p.496-496

2009

Volltextzugriff (PDF)

A Detailed Physical and Transcriptional Map of the Region of Chromosome 20 That Is Deleted in Myeloproliferative Disorders and Refinement of the Common Deleted Region

Genomics (San Diego, Calif.), 1998-05, Vol.49 (3), p.351-362

1998

Volltextzugriff (PDF)

The change process in therapeutic programs for children

Champion, Kim Marie Panetski

1998

Volltextzugriff (PDF)

7 Molecular genetics and cytogenetics of myeloproliferative disorders

Baillière's clinical haematology, 1998-12, Vol.11 (4), p.819-848

1998

Volltextzugriff (PDF)

Comparison of younger and older breast cancer survivors and age‐matched controls on specific and overall quality of life domains

Cancer, 2014-08, Vol.120 (15), p.2237-2246

2014

Volltextzugriff (PDF)

1 – 25 von 153

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(143)
Mit Volltextzugriff
(116)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(153)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Planning an Academic Clinical Trial

Phase III Trial of High-Dose Sequential Chemotherapy With Peripheral Blood Stem Cell Support Compared With Standard Dose Chemotherapy for First-Line Treatment of Advanced Ovarian Cancer: Intergroup Trial of the AGO-Ovar/AIO and EBMT

Expert Commentary on Anal Fissure

Chromosome 20 deletions in myeloid malignancies : reduction of the common deleted region, generation of a PAC/BAC contig and identification of candidate genes

Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR

A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA Working Party of the European Group for Blood and Marrow Transplantation

Clonal Dynamics of Early Responder and Long-Term Surviving CAR-T Cells in Humans

Clonal haemopoiesis in normal elderly women: implications for the myeloproliferative disorders and myelodysplastic syndromes

Abstract CT105: AUTO1, a novel fast off CD19CAR delivers durable remissions and prolonged CAR T cell persistence with low CRS or neurotoxicity in adult ALL

TACTICAL: A phase I/II trial to assess the safety and efficacy of MSCTRAIL in the treatment of metastatic lung adenocarcinoma

Immunotherapy with CD25/CD71-allodepleted T cells to improve T-cell reconstitution after matched unrelated donor hematopoietic stem cell transplant: a randomized trial

Automated Manufacture of Matched Donor-Derived Allogeneic CD19 CAR T-Cells for Relapsed/Refractory B-ALL Following Allogeneic Stem Cell Transplantation: Toxicity, Efficacy and the Important Role of Lymphodepletion

AUTO1, a Novel Fast Off CD19CAR Delivers Durable Remissions and Prolonged CAR T Cell Persistence with Low CRS or Neurotoxicity in Adult ALL

T-Cell Reconstitution after Unrelated Donor HSCT Using Immunotherapy with CD25/71 Allodepleted Donor T Cells: Results of the Randomised Icat Study

Therapy of Paediatric B-ALL with a Fast Off Rate CD19 CAR Leads to Enhanced Expansion and Prolonged CAR T Cell Persistence in Patients with Low Bone Marrow Tumour Burden, and Is Associated with a Favourable Toxicity Profile

A Novel Second Generation CD19 CAR for Therapy of High Risk/Relapsed Paediatric CD19+ Acute Lymphoblastic Leukaemia and Other Haematological Malignancies: Preliminary Results from the Carpall Study

A Novel Low Affinity CD19CAR Results in Durable Disease Remissions and Prolonged CAR T Cell Persistence without Severe CRS or Neurotoxicity in Patients with Paediatric ALL

Automated Manufacture of CAR19 Donor Lymphocytes Incorporated into an Escalated Dose DLI Protocol: Preliminary Results from the CARD Study

452. RegenVOX - Translational Exploitation Strategy for Stem Cell-Based Tissue-Engineered Laryngeal Implants Undergoing Phase I/II Clinical Trial

Vaccination - a Novel Strategy to Improve the Persistence of CD19CAR Transduced T-Cells in Relapsed Paediatric ALL: Preliminary Results from the CD19TPALL Study

Use of G-CSF in Patients with Severe Aplastic Anemia Treated with ATG and Cyclosporine Increases Neutrophils and Decreases Infection Rates and Hospitalization Days but Does Not Improve Long-Term Outcome: Results of a Prospective, Randomized Clinical Trial of the EBMT

A Detailed Physical and Transcriptional Map of the Region of Chromosome 20 That Is Deleted in Myeloproliferative Disorders and Refinement of the Common Deleted Region

The change process in therapeutic programs for children

7 Molecular genetics and cytogenetics of myeloproliferative disorders

Comparison of younger and older breast cancer survivors and age‐matched controls on specific and overall quality of life domains

Suchergebnisse filtern